Anticancer Molecules from Catharanthus roseus by Taher, Zarani M et al.
VOL 30 (3) 2019: 147–156 | REVIEW ARTICLE 
 
147 
 Indonesian Journal of Pharmacy 
Indonesian J Pharm 30(3), 2019, 147-156 | DOI: 10.14499/indonesianjpharm30iss3pp147 indonesianjpharm.farmasi.ugm.ac.id 
Copyright © 2019 THE AUTHOR(S). This article is distributed under a Creative Commons Attribution-ShareAlike 4.0 International 
(CC BY-SA 4.0) 
 
Anticancer Molecules from Catharanthus roseus 
 
Zarani M. Taher1, Farid Agouillal2,3, Lim J. R4, Aina Q. Marof5, Daniel Joe Dailin1,4, Muktiningsih 
Nurjayadi5, Ezzaty N.M Razif6, Sara E. Gomaa7 and Hesham A. El Enshasy1,4,8 
 
1. Institute of Bioproduct Development (IBD), Universiti Teknologi Malaysia (UTM), Johor Bahru, Malaysia. 
2. Research Unit on Analysis and Technological Development in Environment, URADTE, Centre de 
Recherche Scientifique et Technique en Analyses Physico-Chimiques, CRAPC, B.P. 384, RP 42004 Zone 
Industrielle Bou-Ismail, Tipaza, Algeria. 
3. Laboratory of Reaction Engineering, LGR, Faculty of Mechanical Engineering and Process Engineering, 
Houari Boumediene University of Science and Technology, USTHB, PB 32 El Alia, 16075, Bab Ezzouar, 
Algiers, Algeria. 
4. School of Chemical Engineering and Energy, Faculty of Engineering, Universiti Teknologi Malaysia 
(UTM), 81310 Johor Bahru, Malaysia. 
5. Department of Chemistry, Mathematics and Science Faculty, Universitas Negeri Jakarta, Jakarta, 
Indonesia, Jl. Rawamangun Muka, Jakarta Timur, Daerah Khusus Ibukota Jakarta 13220  
6. Faculty of Applied Sciences, Universiti Teknologi Mara Negeri Sembilan, Kampus Kuala Pilah, Pekan 
Parit Tinggi, Kuala Pilah Negeri Sembilan, Malaysia. 72000 
7. Horticulture Research Institute, Agriculture Research Center, 9 ALgamaa Street, Giza, Egypt 
8. Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technology 
Applications (CSAT), New Burg Al Arab Alexandria, Egypt. 
 
Info Article ABSTRACT 
Submitted: 24-02-2019 









Catharanthus roseus is an important medicinal plant found in various parts of 
the world and the bioactive compound has been extracted and used as anti-
cancer agent to treat the cancer over decades. However, the extraction of 
bioactive compound also results in the generation of large quantities of 
pollution with wasted solvents. Toxic pollution occurs when synthetic 
chemicals are discharged or natural chemicals accumulate to toxic levels in 
the environment, causing reductions in wildlife numbers, degrading 
ecosystem functions and threatening human health. This review covers the 
extraction and phytochemical obtained leading to chemical compounds 
related to anti-cancer property of C. roseus. Additionally, recent advances of 
using biological cell cultures were also addressed. Thus, this work can be used 
for further investigation of C. roseus to be undertaken in future for its anti-
cancer property further development and efficient production in drug 
industry.  




Cancer is a disease that in which a group of 
abnormal cells grow uncontrollably beyond usual 
boundaries by disregarding the normal rules of cell 
division and causing a lump known as tumour. 
Tumour formed can then invade adjoining parts of 
the body and spread to other organs, this process is 
known as metastasis which is the major cause of 
death from cancer. According to the World           
Health Organization (WHO), cancer is the second 
leading cause of death globally; nearly 1 in 6 deaths 
is due to cancer. Cancer was responsible for                    
8.8 million deaths in 2015 and approximately 70% 
of deaths from cancer occur in low and middle 
income countries. In additional, according to 
Ministry of Health Malaysia, cancer is one of the 
fatal non-communicable diseases in Malaysia and 
contributed to 13.56% of all deaths in 2015 (Azizah 
et al., 2016). It was the third most common cause of 
death following diseases of circulatory system and 
respiratory system. C. roseus is a plant belonging to 
Apocynaceae family and the name Catharanthus 
comes from Greek word which means ‘pure  
flower’. C. roseus is a perennial plant that commonly 
grows in tropical countries and Catharanthus            
is    more    known    as     Madagascar     periwinkle.  
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C. roseus has long been cultivated for herbal 
medicine and also as an ornamental plant. In Indian 
and Chinese traditional medicine, the extracts have 
been used against numerous diseases such as 
malaria, diabetes and Hodgkin’s disease. It has 
been reported that C. roseus contain more than 70 
different types of chemical constituents such as 
indole type of alkaloids, ajmalicine, serpentine and 
reserpine (Kabesh et al., 2015). The Catharanthus 
alkaloids provide protection against microbial 
infection, abiotic environmental stresses such as 
UV irradiation and are wide importance in clinical 
medicine due to the anti-hypertensive and 
antispasmodic properties (Sain and Sharma, 2013; 
Nejat et al., 2015).  
The Catharanthus alkaloids, vincristine and 
vinblastine which found abundantly in the leaves 
part of the plant inhibited the growth of tumour 
and hence contribute the anticancer property of C. 
roseus (Das and Sharangi, 2017). Vinblastine and 
vincristine were the first natural drugs used in 
cancer therapy and still among the most valuable 
agents used in cancer treatment (Costa et al., 2008). 
Vinblastine and vincristine are able to inhibit the 
cell mitotic and widely used medically to treat 
different kinds of cancers such as breast cancer, 
Hodgkin’s lymphoma and leukemia. Vinblastine 
and vincristine bind to tubulin which is a        
structural protein that can be found in the 
cytoplasm, thereby inhibit the assembly of 
microtubule structures.      
 
GEOGRAPHIC DISTRIBUTION OF C. Roseus 
C. roseus is a tropical or subtropical plant 
which belongs to the family of Apocynaceae and 
known as Madagascar periwinkle. The origin of the 
C. roseus is in Madagascar. The plant is used for the 
medical and decorative in many countries such as 
Malaysia (Ong et al., 2011), India, China, South 
Africa and Mexico (Patel et al., 2012). It is 
incorporates a high salt tolerance which up to 2000 
ppm and typically found close to water level where 
somewhat higher altitudes. C. roseus can grow 20-
60cm high and wide and it also had variety color of 
flower such as pink, white or rosy-purple. The 
flowers are pollinated by butterfly and it self-
fertilized. It has a basal tube which 2.5-3.0cm long 
with a corolla about 2.0-5.0cm diameter. It has five 
sepals which 2-6mm long, narrow and with hairs. 
Besides that, the leaves are oppositely arranged on 
the stem with leaf margin and have pinnate 
venation structure. The length of the blade is about 
2-4 inches. The fruit pod found to be a pair of a 
follicle of about 2.0-4.5 cm long and 3 mm wide 
whereas the fruit characteristic invisible. 
 
MEDICINAL USES OF C. Roseus 
Since the ancient time, people had been used 
this plant as one of the medication alternative for 
various diseases. In most country, C. roseus was 
used for cancer treatment as it is one of the           
plants that produced phytochemical that fights 
cancer. In India, people had been used the leaf 
extract in order to cure bee sting or wasp              
sting. Other than that, in the decoction of the            
leaves was used for diabetes (Nammi et al., 2003). 
The Philippines and African people use the leaf          
infusion for menorrhagia. The raw extracts of the 
leaves and roots were used to treat cancer activity 
and severe diarrhea. In Mauritius, the extract used 
for dyspepsia. The people in the Bahamas used            
the flower decoction to treat asthma, tuberculosis, 
and flatulence. In Malaysia, West Indie and              
Nigeria   the   plant   was   used   to   treat   diabetes.  
 
 
Figure 1. The variety of C. roseus flowers. 
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Following that, people in Madagascar used the leaf 
as evoke vomiting while in Hawaii the extraction 
was used to arrest bleeding (Sharangi, 2017). 
 
EXTRACTION METHODS AND PHYSICO-
CHEMICAL ANALYSIS OF ANTI-CANCER 
MOLECULES FROM C. Roseus 
Chemical solvents that used for bioactive 
compound extraction might lead to environmental 
pollution. Long term exposure to the hazardous 
solvent waste from many industrial processes               
can lead to deleterious effect on respiratory, 
haematological and thyroid functioning (Babu and 
Reddy, 2014). The extraction conducted by using 
water as the solvents is an alternative method to 
extract the bioactive compound. However, in water 
extraction method, high temperature of water is 
required to extract the compound. The increase in 
temperature during extraction might deteriorate 
the quality of extract and degrade the desired 
bioactive compound.  Moreover, water extraction 
method required a long time in order to complete 
the extraction process (Wojdylo et al., 2013). 
C. roseus produces low levels of two dimeric 
terpenoid indole alkaloids, vinblastine and 
vincristine, which are widely used in cancer 
chemotherapy (Costa et al., 2008). The extraction 
and purification of several alkaloids found in                    
C. roseus was first developed by Eli Lilly in the 
1970s using organic solvents methods (Falcao et 
al., 2017). These extraction methods using               
water with sulphuric acid includes four steps such 
as fractionation by partition with benzene, two 
chromatographic columns, crystallization in  
ethanol and sulphuric acid. Extraction of vindoline, 
catharanthin, and vinblastine from C. roseus leaves 
has been extensively carried out using ultrasound 
extraction with dilute or methanol as solvent, 
heating, boiling and refluxing with methanol. 
Additionally, several researches have been          
reported the used of supercritical fluid extraction 
(SFE) to extract phytochemical from C. roseus               
a (Verma et al., 2008; Falcao et al., 2017). Several 
phytochemical compounds obtained from C. roseus 
using advances technology to develop anti-cancer 
property (Table I). 
 
CHEMICAL COMPOSITION, STRUCTURE 
AND MODE OF ACTION OF ANTICANCER 
MOLECULES OF C. Roseus 
C. roseus produce several indole alkaloids, 
named as Vinka alkaloids, which is widely used       
as antimitotic drugs in the treatment of cancer 
(Almagro et al., 2015). This includes natural 
products like vincristine and vinblastine, the first 
anticancer agents used clinically (Sottomayor et al., 
2005) and their semisynthetic derivatives like 
vindesine, vinorelbine and vinflunine (Van der 
Heijden et al., 2004; Moudi et al., 2013). In 
comparison with vinblastine structure, the 
velbanamine moiety characterize vinflunine and 
vinorelbine which are both synthesized from the 
precursor alkaloids catharanthine and vindoline to 
increase their therapeutic action (Nirmala et al., 
2011; Ngan et al., 2000). 
Vinca alkaloids provoke apoptosis and cell 
growth repression by altering the microtubular 
dynamics. These Microtubules (MTs) are 
components of the cytoskeleton which are the 
major constituents of mitotic spindles involved in 
chromosome separation during meiosis and 
mitosis, they are also involved in maintaining cell 
structure, transport and many others cellular 
processes (Wang et al., 2012; van der Heijden et al., 
2004). The basic units of the MTs are α-tubulin and 
β-tubulin heterodimers which are in a dynamic 
polymerization and depolymerization at their 
ends; this assembly and disassembly of the MT 
polymers, also called as “treadmilling” and 
“dynamic instability”, is regulated by the binding of 
tubulin and guanosine 5-triphosphate (GTP), then, 
any destabilization or interruption of this dynamics 
can arrest the cell cycle and lead to programmed 
cell    death    or    apoptosis   (Jordan   et  al.,  2002).  
Since, two groups of destabilizers are 
distinguished; the first group compounds are the 
MT-stabilizing agents that prevent the 
depolymerization and the second group 
compounds are MT-depolymerizing agents that 
inhibit MTs assembly (Perez et al., 2009; Islam and 
Iskander, 2004). 
To arrest tumour cells cycle during mitosis, 
Vinca alkaloids and their derivatives act by binding 
at the surface between two tubulin heterodimers 
next to the exchangeable GTP-binding site and 
depolymerizing the MTs (Morris and Fornier, 2008; 
Bolanos-Garcia, 2009). The affinity of both natural 
Vinca alkaloids from C. roseus or their semi-
synthetic analogues and derivatives for tubulin 
heterodimers appears to be the same but it is 
characterized by the decrease of the overall 
equilibrium constants as following order: 
vincristine > vinblastine > vinorelbine > vinflunine 
(Gigant et al., 2005; Okouneva et al., 2003).  The 
complexes of these alkaloids with α, β-tubulin are 
stabilized by van der Waals forces and electrostatic 
interaction energy through common binding site.  
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Also, this electrostatic interaction is improved in 
the case of vinflunine probably due to its two 
fluorine atoms that differentiate it from vinorelbine 
(Coderch et al., 2012; Miyamoto et al., 2003), then, 
tubulin heterodimers binding is ensured by the 
vindoline domain, while the cytotoxic effect is 
provided by the catharanthine domain (Sertel et al., 
2011). Several authors have reported that Vinca 
alkaloids acts following dose-dependent model 
leading to stop the cell mitosis when the levels of 
Vinca alkaloids are low, then, the cells die after a 
long time of incubation. However, at high 
concentration, Vinca alkaloids stop the mitosis of 
the tumoral cells by the formation of paracristals 
(large tubulin polymers) and immediately provoke 
the cell death (Takanari et al., 1990; Attard et al., 
2006). New mechanisms of action of these alkaloids 
have been recently reported by many authors,  
then, they can interplay with MTs associated 
protein, they can interact with calmodulin and they 
can inhibit the amino acid metabolism (Barbier et 
al., 2013; Schutz et al., 2011). However, differences 
of Vinca alkaloids activity were observed with               
this new mode of action. Then, the better efficacy         
of vinflunine in comparison with vinblastine 
against murine tumours and human tumour 
xenografts can be explained by its interaction              
with calmodulin in spite of its lower binds                        
to tubulin than vinblastine or vincristine (Van               
der  Heijden   et al.,  2004;   Almagro   et al.,   2015).  
Table I. Phytochemicals extracts and fractions obtained from C. roseus 
 
No. Bioactive Phytochemicals Extraction/determination method References 
1 
Vindoline, vinblastine, catharanthine, 
vincristine 
Ultraviolet-c treated CMCs extraction Moon et al., 2018 
2 
Vincristine, vinblastine, ajmalicine, 
catharanthine, serpentine, vindoline 
Ultra HPLC-quadrupole time-of-flight 
(UPLC-Q-TOF) mass spectrometry method 
 




Modular transcriptional control of MIA 
(monoterpoid indole alkaloid) 
biosynthesis 
Schweizer et al., 
2018 
4 
Vincristine, vinblastine, vindesine, 
ajmalicine, ajmaline, reserpine, 
vindoline 
Ultra HPLC – tandem mass spectrometry 
Kumar et al., 
2018 
5 Vinblastine, vincristine Yeast extract elicitation 





HPLC and qualification reverse – 
transcription polymerase chain reaction 
qRT-PCR, ultraviolet-C 






HPLC with diode array detector 
(HPLC-DAD) 
Liu et al., 2016 
 
8 Catharanthine and vindoline Centrifugal partition chromatography 
Kotland et al., 
2016 
9 
Cathacunine, dimeric  indole 
alkaloids 
Nuclear factor kappa-light chain-enhancer 
of activated B cells(𝑁𝐹𝐾𝐵) and c-jun N 
terminal kinase (JNK), HPLC 




vindolinine, vincristine, vinblastine, 
anhydrovinblastine 
HPLC –DAD method simultaneous analysis 
of terpenoid indole alkaloids(TIAs) 
Pan et al., 2016 
 
11 
Vincristine, vinblastine and 
catharanthine 
Agilent HPLC, C18 column, HPLC with UV 




Vindoline, vindolidine, vindolinine, 
vindolicine, serpentine and perivine 
NMR, MS, UV and IR 
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Other indole alkaloids from C. roseus were reported 
as cell growth inhibitors. However, their mechanism 
of action is still not well-known. Catharoseumine, 
the monoterpenoid indole alkaloid isolated from C. 
roseus by Wang et al. (2012), possess a unique 
peroxy bridge moiety and show cytotoxic effect 
when tested in human tumour cell lines but only a 
moderate cytotoxic effect against HL-60 cell line. In 
1974, Eli Lilly Company has patented a preparation 
process of vinposidin (Leurosidin) used as an 
antimitotic agent (Eli Lilly, 1974; Keglevich et al., 
2012) (Table II).  
PRODUCTION OF ANTICANCER COMPOUNDS 
OF C. Roseus IN SUBMERGED CULTURE SYSTEM 
Beside the conventional approach of using 
grown plant in the field as initial materials of              
the production of anticancer compound of C.  
roseus, during the recent years many research have        
been focused on the cultivation of plant cells for 
more efficient production of anticancer compound. 
This method of cultivation offer many advantages 
such as: reducing the number of purification             
steps, highly efficient production system in            


























Figure 2. Chemical Structure of main bioactive alkaloids from  C. roseus Vinca alkaloids. 
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process  under sterile conditions to cope with the 
cGMP requirements for the production of bioactive 
drugs. Therefore, in recent years production of high 
value medicinal product by C. rosesus is carried out 
in submerged cultivation systems either using 
shake flask or different types of bioreactors (Ducos 
et al., 2009; Mujib et al., 2014). Bioreactors of 
different scales have been proven to be suitable for 
the cultivation of hairy root lines of C. roseus for 
large scale production of ajmalicine, serpentine, 
and catharanthine (Verma et al., 2012). Other 
anticancer bioactives such as vincristine and 
vinbalastine were successfully produced in stirred 
tank bioreactor. The maximal production of these 
alkaloid is carried out under uncontrolled pH and 
aeration rate of 0.5 v/v/min. The alkaloid 
production was 13.47 and 7.94 folds higher 
compared to intact plant for vincristine and 
vinblastine, respectively (Taha et al., 2014). 
However, addition of chemical to induce stress on 
cells can increase also the alkaloid compound 
production. It has been reported that addition of 
chromium to culture medium in very low 
concentration (in range between 10-100 µM) 
reduced cell growth concomitant with a significant 
increase in vinblastine and vincristine production 
(Rai et al., 2014). Addition of sodium chloride to 
increase osmotic stress in culture can lead also to 
various stress signalling, enzyme activities and 
increase both of vinblastine and vincristine 
production as well (Fatima et al., 2015). Other 
study also reported that the addition of fungus 
elicitor of Aspergillus flavus lead to a significant 
stimulation of cell growth and increase in both 
vinblastine and vincristine production (Tonk et al., 
2016). Recent research reported on the positive 
effect of yeast extract supplementation to culture 
medium on increasing the vinblastine and 
vincristine when added in concentration as low as 
1.5g/L in suspension culture of C. roseus (Maqsood 
and Abdul, 2017).  
 
CONCLUSION  
During recent years, the demand for natural 
bioactive compounds have been increased as 
alternative or in combination with chemo- and 
radiotherapy in cancer treatment to reduce their 
side effects. Based on many years research, C. 
roseus is considered as one of the plant biofactory 
for the production of highly potent anticancer 
molecules. Of different compounds studied, 
vincristine and vinblastine are the widely used 
compounds in pharmaceutical industries. 
However, other molecules such as cathachunine, 
catharanthine, vinflunine, and vinorelbine have 
also high potential application as anticancer 
compound based on many in vivo and in vitro 
studies. The most attractive features of this plant is 
Table III. Alkaloids from C. roseus used as antimitotic drugs. 
 
Molecules Cancer Type Targeted In vitro / in vivo testing Reference 
Vincristine 
(Oncovin) 
Leukaemia HL60 human acute 
promyelocytic leukemia cells, 
K562 human chronic 
myelogenous leukemia cells 
and EA.hy926 human 
umbilical vein cells  
Wang et al., 2016 
Lymphomas B-cell lymphoma cell line Qiu et al., 2018 
Vinblastine 
(Velban) 
Leukimia Chronic Lymphocytic 
Leukaemia (CLL) 
Bates et al., 2014 
Vinorelbine, 
(Navelbine) 
Solid tumours Clinical trials   Bahleda et al., 2018 
Breast cancer Clinical trials  Nazir et al., 2016 
Non-Small-Cell Lung cancer Clinical trials  Nazir et al., 2016 
Vinflunine Non-Small-Cell Lung cancer C Krzakowski et al., 2010 
Urothelial carcinoma Human patients Schinzari et al., 2018 
Catharanthine Colorectal Carcinoma Human Colorectal Carcinoma 
Cell Line (HCT 116). 
Siddiqui et al, 2010 
Cathachunine  Leukemia  B cells (NF-κB) and c-Jun N-
terminal kinase (JNK) 
pathways 
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the ability to cultivate in submerged culture using 
bioreactors. This make it easy to cultivate and 
production of the anticancer compounds in high 
concentration, in shorter time, and under fully 
sterile condition with full compliance with cGMP 
for drug manufacturing.  
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